InvestorsHub Logo
Followers 1183
Posts 134793
Boards Moderated 3
Alias Born 08/27/2003

Re: None

Saturday, 10/22/2016 7:30:31 AM

Saturday, October 22, 2016 7:30:31 AM

Post# of 146291
A message from Dr. Seymour
[edited to suit TOS (I hope)]

Message to this board from Gene Seymour, taken from an email to me from GS sent Dec 2, 2014, at 02:11 ET.

Note: I’ve removed a possibly problematic word and replaced it with “someone with whom I differ”

Otherwise, Dr. S’s message remains exactly as he wrote it.
Quote:
Had dinner with an investment advisor whose clients hold large positions in NNVC

Against my will, he showed me a recent … post [from someone with whom I differ] that said tox wouldn’t be completed in 2014 (true because it didn’t start until October)

Also, [someone with whom I differ] complained that the NYSE move wasn’t good (nonsense since we now have 65 institutions as investors and we’re on the Russell 2000. In addition, it enabled us to raise $35M giving us a $42M war chest). With the market crashing, we would be going out of business had we not done the uplift and the raise

We’re now well positioned for success

The plant is completed and scale-up continues

A contract with USAMRIID has been signed (What a coup that was)

Ebola will be ready to ship as soon as USAMRIID comes back on line after their annual cleaning of the facility

We created the MERS drug for the British government (remember that disease) in short order and if Ebola hadn’t come along, they would have tested it by now

We’re actively hiring and a group of new scientists are starting this month

All of the TheraCour scientists are under Dr Diwan’s direction so they’re essentially full-time NNVC employees

The lawsuit with Brammel was settled

It’s been a helluva good 14 months

What most people don’t seem to realize is that any other pharma would spend 12-14 years and $2.55B taking a drug to market

We plan to do it in 10 years for $50M

And if they want to do a second drug, they have to start from scratch.

For us, the time for new drug development is measured in weeks, not years

That’s the most amazing thing about the platform technology concept

Gene


Eugene Seymour MD MPH
Chief Executive Officer
NanoViricides, Inc
eugene@nanoviricides.com
www.nanoviricides.com
310-486-5677
"NNVC" on the New York Stock Exchange

The SwingTrade Portfolio was up 36.2% in 2014, 83.5% in 2013, and 546.6% since inception.
http://investorshub.advfn.com/boards/read_msg.aspx?message_id=110307454

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NNVC News